Muscular Diseases
Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE.
Subtype terms (27)
More specific conditions that are subtypes of Muscular Diseases in the MeSH hierarchy.
- Arthrogryposis
- Compartment Syndromes
- Contracture
11 drugs (9 approved, 2 experimental)
- Craniomandibular Disorders
- Eosinophilia-Myalgia Syndrome
- Fatigue Syndrome, Chronic
76 drugs (43 approved, 33 experimental)
- Fibromyalgia
141 drugs (86 approved, 55 experimental)
- Isaacs Syndrome
- Medial Tibial Stress Syndrome
- Mitochondrial Myopathies
13 drugs (7 approved, 6 experimental)
- Muscle Cramp
33 drugs (22 approved, 11 experimental)
- Muscle Neoplasms
- Muscle Rigidity
2 drugs approved
- Muscle Spasticity
39 drugs (23 approved, 16 experimental)
- Muscle Weakness
55 drugs (35 approved, 20 experimental)
- Muscular Disorders, Atrophic
7 drugs experimental
- Musculoskeletal Pain
40 drugs (29 approved, 11 experimental)
- Myalgia
60 drugs (27 approved, 33 experimental)
- Myofascial Pain Syndromes
33 drugs (20 approved, 13 experimental)
- Myopathies, Structural, Congenital
7 drugs (5 approved, 2 experimental)
- Myositis
71 drugs (29 approved, 42 experimental)
- Myotonic Disorders
5 drugs (4 approved, 1 experimental)
- Myotoxicity
- Paralyses, Familial Periodic
- Polymyalgia Rheumatica
23 drugs (20 approved, 3 experimental)
- Rhabdomyolysis
6 drugs approved
- Tendinopathy
67 drugs (43 approved, 24 experimental)
Drugs by status
Approved for this indication (1)
Phase 4 trials (4)
Phase 3 trials (3)
Phase 2 trials (5)
Phase 1 trials (10)
Other trials (6)
Organizations
Organization Involved with Phase 4 Indications (9)
Organization Involved with Phase 3 Indications (12)
Organization Involved with Phase 2 Indications (27)
- AbbVie
- Eli Lilly
- Grifols
- Bioelectron
- Leadiant Biosciences, Inc.
- Ra Pharmaceuticals
- Reata Pharmaceuticals, Inc.
- Capricor Inc.
- National Human Genome Research Institute (NHGRI)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- National Institute of Environmental Health Sciences (NIEHS)
- National Institute of Neurological Disorders and Stroke (NINDS)
- National Institute of Nursing Research (NINR)
- Harvard University
- University of Washington
- New York University
- Radboud University
- University of Manchester
- Peking University
- University of California, Davis
- University of California, Los Angeles
- Hebrew University
- Karolinska Institute
- Washington University in St. Louis
- National Center for Advancing Translational Science (NCATS)
- Audentes Therapeutics
- Dynacure
Organization Involved with Phase 1 Indications (10)
Organization Involved with Other Experimental Indications (18)
- National Center for Research Resources (NCRR)
- National Heart, Lung, and Blood Institute (NHLBI)
- University of Roma La Sapienza
- Cornell University
- McGill University
- Silesian University of Medicine
- Translational Research Informatics Center, Kobe, Hyogo, Japan
- University of Groningen
- University of Iowa
- University of Rochester
- Utrecht University
- University of Copenhagen
- University of Amsterdam
- University of Montpellier
- University of Oxford
- University of Helsinki
- Erfelijke Stofwisselingsziekten Nederland
- Institute for Molecular Medicine